Elucidation of chemical background enhances interpretation of novel oligonucleotide drug impurities by mass spectrometry
Sample introduction into a mass spectrometer (MS) is associated with the likelihood of introducing background chemicals, which may form adducts with the analyte of interest such as oligonucleotide therapeutic drugs, significantly interfering with the interpretation of the MS data. Here we examine the variables affecting the formation of adducts. We found that most of the chemical species forming adducts are present in the carrier stream as impurities. Adduct formation is affected by experimental parameters but also depends on the oligonucleotide sequence. We introduce a novel and practical approach to identify unknown oligonucleotide adducts which includes tandem MS (MS/MS) interpretation and comparison of the accurate mass difference between the parent oligo and adduct, with the masses of the impurities in the chemical background. We give exhaustive examples of the steps in the identification of 10 oligonucleotide adducts. Knowledge about the unwanted interactions of analytes of interest with extraneous chemical entities can increase the accuracy of MS-based interpretations and conclusions and is of interest to all areas of MS applications.
Authors
- Claus Rentel (ORCID: https://orcid.org/0000-0002-7730-4040)
- Stilianos G. Roussis (ORCID: https://orcid.org/0000-0002-3704-6403)
- Kym Bradley
Institutions
- Ionis Pharmaceuticals (United States) (US)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1038/s41598-026-77146-9
- Primary Topic
- Mass Spectrometry Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00